Boehringer’s decision to drop development of a joint candidate will have no effect on the collaboration with Gubra, the Danish biotech company’s CEO Henrik Blou emphasizes.
发布者:BY ULRICH QUISTGAARD,转转请注明出处:https://robotalks.cn/gubra-after-dropped-obesity-candidate-now-comes-the-dialog-with-boehringer-ingelheim/